Physical & Functional Assessments in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, CGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical and Translational Sciences grants UL1 TR000448 and KL2 TR000450 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Learning Objectives At the conclusion of this application-based activity, participants should be able to: 1. Identify appropriate assessment instruments to use for a given set of symptoms or patient complaints. 2. Identify a variety of screening and assessment tools (e.g., mini-cog exam, Katz index of activities of daily living, geriatric depression scale, and others). 3. Apply principles to a geriatric patient case. Geriatric Assessment Full assessment includes Physical assessment Laboratory tests Review of medical problems and medications Cognitive assessment Functional assessment Social Assessment Family history Assessment tailored to patient Age Frailty Living situation Includes caregivers / family Includes interdisciplinary team Linnebur SA. Et als. Fundamentals of geriatric pharmacotherapy: an evidence-based approach. 1 st ed. Bethesda (MD): American Society of Health-System Pharmacists; 2010. p 71-90.
Geriatric Assessment - Brief Topics Physical Assessment Observations Vitals signs, weight Eyes, ears, mouth, skin Cardiovascular, musculoskeletal, abdominal Urologic, neurologic, others Williams ME, et al Case-based geriatrics: a global approach. 1 st ed. New York:McGraw-Hill;2011. p 59-68. Linnebur SA. Et als. Fundamentals of geriatric pharmacotherapy: an evidence-based approach. 1 st ed. Bethesda (MD): American Society of Health-System Pharmacists; 2010. p 71-90. Kane RL, Ouslander, Abrass IB. Essentials of clinical geriatrics. 5 th ed. New York: McGraw-Hill. 2004 Geriatric Assessment - Brief Topics History Social History Tobacco, alcohol, illicit drug-use Full Medication History/Medication Reconciliation Includes where medications are stored and pharmacy used Past Medical History Helps better understand appropriateness Drug-induced adverse events/prescribing Cascade Linnebur SA. Et als. Fundamentals of geriatric pharmacotherapy: an evidence-based approach. 1 st ed. Bethesda (MD): American Society of Health-System Pharmacists; 2010. p 71-90.
Medication Assessment Immunizations Influenza (inactivated) Standard dose versus high dose Pneumococcal PPSV23 and PCV13 If 65 and no PPSV23 or no PCV13 65 and PPSV23 and no PCV13 65 and PCV13 and no PPSV23 <65 when administered PPS23 and now 65 Then PCV13 followed by PPSV23 (6-12 months later) PCV13 one year after PPSV23 PPSV23 6-12 months after PCV13 PCV13 on year after (initial) PPSV23 then PPSV23 at least one year after PCV13 and at least 5 years after initial PPSV23 Granados et al. N EnglJ Med. 2014;371:635-645. Izurietaet al. Lancet Infect Dis. 2015;15(3):293-300. Richardson et al. Clin Infect Dis. 2015;61(2):171-176. http://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html Medication Assessment Medication Adherence Understand who is in charge and what method of administration is used Intentional versus non-intentional non-adherence Intentional costs or adverse effects Non-Intentional too complex/forgets (or takes too much) Medication adherence tools Modified-Morisky scale Trails B test Medication adherence actions Pill counts Fill history per pharmacy Shalansky et al. Ann Pharmacother. 2004;38(9):1363-1368. Chung et al. J Am Geriatr Soc. 2015;63(S1):S76.
Medication Assessment Medication Duration Certain medications should only be taken for a specific duration Extended exposure to these medications may provide no further benefit and contribute to harm These, plus other medications, should have initial year of started medications documented or assessed to avoid overtreatment Medication Duration Risk Bisphosphonates 3-5 years Atypical fractures PPI for GERD 1 month Fractures, malabsorption, electrolyte issues (Mg) Dual-Antiplatelet 1-2.5 years GI Bleed Gedmintas et al. J Bone Miner Res. 2013;28(8):1729-1737. Yang et al. JAMA. 2006;296(24):2947-2953. Cutlip et al. Topic 1572 Version 42.0. Accessed July 11,2015. Active Learning You are the consultant pharmacist at a short-term rehabilitation. You ve made it a point to ensure vaccinations are up-to-date. You are evaluating a 68 year old patient with history of HTN, smoking, and recent stroke. Her vaccinations include: Influenza 10/2014 PPSV23 7/2017 Tdap Booster 5/2012 Hepatitis A/B titers present What vaccinations would you recommend a) Vaccinations up-to-date b) Herpes Zoster only c) PCV13 only d) Both Herpes Zoster and PCV13
Active Learning When performing a medication assessment, which of the following is the most important to assess how long the patient has been taking the medication? a) Tamoxifen for breast cancer b) Loop diuretic for CHF c) 5ARI for BPH d) Pravastatin for CAD prevention Other Assessments Cognitive Mood Behavior Functional Pain Others
Cognitive Assessment Test Abbreviation Interpretation Comment Mini-Mental State Exam Montreal Cognitive Assessment St. Louis University Mental Status Exam Short Blessed Test Alzheimer s Disease Assessment Scale Cognitive subscale MMSE MoCA SLUMS SBT ADAS-cog 24-30 normal; 18-23 mild; 10-17 moderate; <10 severe 26-30 normal; <26 MCI or dementia 27-30 normal; 21-26 MCI; <21 dementia 0-4 Normal; 5-9 questionable; 10 or more dementia Changes in 4 points considered significant Williams ME, et al. Case-based geriatrics: a global approach. 1 st ed. New York:McGraw-Hill;2011. p 59-68. Nasreddineet al. J Am GeriatrSoc. 2005;53(4):695-9 Rockwood et al. BMC Neurology. 2007;7(26):doi:10.1186/1471-2377-7-26. Carpenter et al. Acad Emerg Med. 2011;18(4):374-384. 30 point evaluation; copyrighted 30 point evaluation; validated in >20 languages; more sensitive than MMSE Rarely used; Normal, MCI, Dementia Evaluates 6 items (28 total points); more sensitive than MMSE Used for Research Purposes; 0-70 0=no cognitive impairment Cognitive Assessment Clinical Dementia Rating (CDR) Memory Orientation Judgement/ Problem Solving Community Affairs Home/Hobbies Personal Care Impairment None (0) Questionable (0.5) Mild (1) Moderate (2) Severe (3) Morris et al. Neurology. 1993;43:2412-14. http://www.dementia-assessment.com.au/global/cdr_scale.pdf https://www.alz.washington.edu/cdrnacc.html
Executive Function Trail-Making Tests TMT-B Variable cut-offs >273 seconds impaired http://www.nhtsa.gov/people/injury/olddrive/olderdriversbook/pages/trail-making.html http://doa.alaska.gov/dmv/akol/pdfs/uiowa_trailmaking.pdf Neuropsychiatric Assessment Depression Geriatric Depression Scale (GDS) Long-Form (30 items) Short-Form (15 items) Patient Health Questionnaire PHQ-2 and PHQ-9 Cornell Scale for Depression in Dementia Ratings based on patient signs and symptoms over one week Scale of 0,1,2 with >12 is probable depression Beck Depression Inventory Self-rated scale containing 22 questions Hamilton Depression Training rated Needs existing diagnosis of depression Kane RL, et alessentials of clinical geriatrics. 5 th ed. New York: McGraw-Hill. 2004 Thielke S et al. Case-based geriatrics: a global approach. 1 st ed. New York: McGraw-Hill;2011. p 491-504. Ownby et al. Am J Geriatr Psychiatry. 2001;9:217-224.
Neuropsychiatric Assessment Behavior Behavioral Pathology in Alzheimer s Disease Rating Scale (BEHAVE-AD) Neuropsychiatric Inventory (NPI) BEHAVE-AD and NPI-Q used in research settings Neuropsychiatric Inventory Questionnaire (NPI-Q) Can be completed in <5 minutes and validated against NPI 13 Yes/No and Severity questions Delusions, hallucinations, agitation, depression, anxiety, elation, apathy, Disinhibition, irritability, motor disturbance, nighttime behaviors, appetite Linnebur SA. Et al.. Fundamentals of geriatric pharmacotherapy: an evidence-based approach. 1 st ed. Bethesda (MD): American Society of Health-System Pharmacists; 2010. p 71-90. Kaufer et al. J Neuropsychiatry Clin Neurosci. 2000;12(2):233-239. https://www.alz.washington.edu/nonmember/uds/docs/ver2/ivpforms/b5.pdf Functional Assessment Function Measures of Physical Function (ADLs & IADLs) Ability to perform without human assistance Independent Ability to perform with some human assistance Partially independent Inability to perform, even with assistance Dependent Vulnerable Elders Survey Predictors risk for death or functional decline Assesses ADLs/IADLS Shopping, light housework, finances, walking across room, and bathing Patient characteristics/ Disease states Age, Self-rate health, and disease states dementia, DM, stroke, MI, valvular disease, etc Score 3 or more are 4x at risk compared to <3 Kane RL, et al. Essentials of clinical geriatrics. 5 th ed. New York: McGraw-Hill. 2004 Katz S, et al. Gerontologist. 1970;10(1):20-30. http://www.rand.org/health/projects/acove/survey.html
Functional Assessment Falls/Balance Name Abbreviation Description Interpretation Timed Up and Go Test Romberg Test Five Times Sit to Stand TUG RT FTSS From seated position rise, walk 3M, return and sit Stand with feet together with eyes open and closed Arms crossed, stand and sit 5 times <20 seconds independent >14 seconds fall risk >14 seconds fall risk Shumway-Cook et al. Physical Therapy. Buatosis, et al. J Am GeriatrSoc. 2008;56(8):1575-1576. Assessment for Pain P Provoking Q Quality R Region/Radiates S Severity T Timing / Temporal U Impact on U
Pain Scales Scales for Assessing Pain Severity 0-10 Numeric Rating Scale Verbal Descriptor Faces Pain Scale http://www.wongbakerfaces.org/ Pain Thermometer http://www.geriatricpain.org/content/assessment/intact/page s/painthermometerscale.aspx Nutritional Assessment Mini-Nutritional Assessment (MNA) Mini-Nutritional Assessment-Short Form (MNA-SF) http://www.mna-elderly.com/ Malnutrition Universal Screening Tool (MUST) http://www.bapen.org.uk/screening-formalnutrition/must/introducing-must Leigh AE et al. Case-based geriatrics: a global approach. 1 st ed. New York: McGraw-Hill;2011. p 465-79. Stratton RJ et al. Br J Nutr. 2006;95(2):325-30.
Nutritional Assessment Simplified Nutrition Assessment Tool (SNAQ) Subjective Global Assessment (SGA) Seniors in the community: Risk Evaluation for Eating and Nutrition Version II (Screen II) Leigh AE et al. Case-based geriatrics: a global approach. 1 st ed. New York: McGraw-Hill;2011. p 465-79. Other Assessments Abnormal Involuntary Movement Scale (AIMS) http://www.cqaimh.org/pdf/tool_aims.pdf Tests for tardive dyskinesia over time Dopamine blocking agents 1 st generation antipsychotics (AP)> 2 nd generation AP Other DA blocking agents metoclopramide Highest level of severity Not simply adding up numbers Rush JA. Handbook of Psychiatric Measures, American Psychiatric Association, 200, 166-168.
Active Learning You would like to incorporate a cognitive assessment into clinic. What is the best/most practice assessment tool that can be used? a) MMSE b) MOCA c) ADAS-Cog d) CDR Active Learning You would like to incorporate an assessment for depression screening into clinic. All of the following tools, EXCEPT should be considered. a) GDS b) PHQ-9 c) Cornell d) Hamilton
Conclusion There are many assessments that can be performed in older adults Pharmacists should be able to perform medicationrelated assessments Pharmacists should be able to understand other assessments